Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-04-18 @ 12:52 PM
Study NCT ID:
NCT00065533
Status:
COMPLETED
Last Update Posted:
2007-06-22
First Post:
2003-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
7491
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None